27
Participants
Start Date
October 5, 2020
Primary Completion Date
November 28, 2022
Study Completion Date
December 13, 2025
Atezolizumab
Given IV
Biopsy Procedure
Correlative studies
Biospecimen Collection
Correlative studies
Computed Tomography
Undergo CT scan
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
National Cancer Institute Developmental Therapeutics Clinic, Bethesda
National Institutes of Health Clinical Center, Bethesda
NCI - Center for Cancer Research, Bethesda
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
University of Florida Health Science Center - Gainesville, Gainesville
Vanderbilt University/Ingram Cancer Center, Nashville
Ohio State University Comprehensive Cancer Center, Columbus
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
M D Anderson Cancer Center, Houston
USC / Norris Comprehensive Cancer Center, Los Angeles
Dana-Farber Cancer Institute, Boston
University Health Network-Princess Margaret Hospital, Toronto
National Cancer Institute (NCI)
NIH